Skip to main content Accessibility help
×
Hostname: page-component-cd9895bd7-jn8rn Total loading time: 0 Render date: 2024-12-28T02:30:46.190Z Has data issue: false hasContentIssue false

14 - Multiple sclerosis

from Part II - Neurological diseases

Published online by Cambridge University Press:  29 September 2009

Albert Hofman
Affiliation:
Erasmus Universiteit Rotterdam
Richard Mayeux
Affiliation:
Columbia University, New York
Get access

Summary

Introduction

A large part of neurological disabilities of the young adult population of developed countries is due to multiple sclerosis. The number of persons affected by MS is at least 250,000 in the United States and of the same order in the European Union, this latter estimate being based on numerous studies conducted in individual European countries. With few exceptions, onset of MS occurs between 15 and 50 years, with a marked peak between 25 and 35 years. The disease is more frequent in women than in men; the female/male ratio ranges from 1.5 to 2.0.

Macroscopically, the pathology of MS is characterized by lesions widely distributed in the white matter of the brain and spinal cord. Microscopic examination of the lesions shows the typical breakdown of the myelin sheath. The MS lesions have a perivenous distribution. They contain macrophages and lymphocytes, and small amounts of myelin basic protein.

All neurological functions are affected by MS; subsequent disabilities include assistance required for walking, bladder dysfunction, loss of visual acuity. Until now, no treatment has a definitively established durable effect on disease course.

This short chapter will not be an extensive review on MS. It will focus on the most prominent features of the etiology, natural history, and treatment of the disease.

Etiology

There is strong evidence that MS is an immune disease, but its cause and pathogenesis are unknown. However, hundreds of epidemiological studies on MS prevalence which have been conducted throughout the world (approximately 200 were recorded as early as 1980) provide evidence that the disease involves the interplay of genetic susceptibility factors and environmental exposures, possibly to infectious agents.

Type
Chapter
Information
Investigating Neurological Disease
Epidemiology for Clinical Neurology
, pp. 196 - 204
Publisher: Cambridge University Press
Print publication year: 2001

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Save book to Kindle

To save this book to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×